pan
zy
peng
cocorrespond
author
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
rational
late
decemb
outbreak
acut
respiratori
ill
offici
name
coronaviru
diseas
emerg
wuhan
china
spread
across
whole
countri
world
data
need
understand
clinic
characterist
diseas
studi
epidemiolog
clinic
featur
outcom
patient
method
perform
singl
center
retrospect
case
seri
studi
patient
laboratori
confirm
pneumonia
univers
hospit
median
age
year
male
patient
histori
exposur
huanan
seafood
market
compar
nonsever
pneumonia
patient
median
age
sever
patient
significantli
older
like
chronic
comorbid
common
symptom
sever
patient
high
fever
anorexia
dyspnea
admiss
patient
show
leukopenia
show
lymphopenia
addit
sever
patient
suffer
higher
rate
coinfect
bacteria
fungu
like
develop
complic
februari
patient
discharg
patient
die
sever
case
receiv
icu
care
transfer
gener
ward
due
reliev
symptom
mortal
rate
sever
patient
icu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
medrxiv
preprint
conclus
epidem
spread
rapidli
humantohuman
transmiss
patient
elder
age
chronic
comorbid
blood
leukocytelymphocyt
count
procalcitonin
level
coinfect
sever
complic
might
increas
risk
poor
clinic
outcom
abstract
word
late
decemb
outbreak
acut
respiratori
ill
offici
name
coronaviru
diseas
emerg
wuhan
china
bronchoalveolar
lavag
sampl
infect
patient
novel
betacoronaviru
isol
identifi
caus
agent
current
studi
demonstr
share
homolog
two
batderiv
sever
acut
respiratori
syndrom
sar
relat
coronavirus
bat
may
like
natur
host
howev
whether
transmit
directli
bat
intermedi
host
still
uncertain
although
epidemiolog
studi
indic
common
link
initi
diagnos
patient
huanan
seafood
market
wuhan
increas
number
later
confirm
case
involv
infect
patient
without
histori
contact
implic
market
travel
wuhan
famili
cluster
type
infect
report
humantohuman
transmiss
confirm
respiratori
droplet
contact
main
transmiss
rout
recent
report
also
suggest
exist
fecalor
transmiss
rout
base
recent
largescal
epidemiolog
survey
latenc
period
may
extend
day
even
though
proport
patient
long
incub
period
small
medium
incub
period
remain
short
day
report
ill
rang
patient
littl
symptom
patient
sever
ill
die
main
clinic
manifest
includ
fever
cough
fatigu
dyspnea
compar
young
middleag
patient
elder
infect
patient
chronic
comorbid
increas
risk
develop
organ
dysfunct
includ
shock
acut
respiratori
distress
syndrom
ard
acut
cardiac
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
injuri
acut
kidney
injuri
result
higher
mortal
rate
howev
clinic
featur
sever
nonsever
case
yet
well
describ
unlik
sarscov
display
highli
contagi
infecti
even
asymptomat
period
present
effect
medic
vaccin
infect
februari
nation
health
commiss
china
report
total
confirm
suspect
case
death
provinc
across
countri
addit
confirm
case
also
report
abroad
differ
countri
studi
perform
comprehens
explor
epidemiolog
clinic
laboratori
radiolog
characterist
hospit
patient
laboratoryconfirm
includ
sever
patient
nonsever
patient
zhongnan
hospit
wuhan
univers
wuhan
china
januari
februari
retrospect
singlecent
studi
recruit
patient
confirm
diagnos
accord
interim
guidanc
januari
februari
zhongnan
hospit
wuhan
univers
wuhan
china
studi
approv
nation
health
commiss
china
ethic
commiss
zhongnan
hospit
written
inform
consent
waiv
ethic
commiss
emerg
infecti
diseas
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
procedur
patient
confirm
infect
presenc
pharyng
swab
specimen
detect
realtim
rtpcr
use
gene
pcr
kit
biogerm
cat
shanghai
china
accord
protocol
describ
previous
diagnost
criteria
rtpcr
result
base
recommend
nation
institut
viral
diseas
control
prevent
china
http
confirm
case
treat
effect
isol
protect
condit
sever
critic
case
admit
emerg
depart
icu
ward
patient
monitor
vital
sign
bodi
temperatur
heart
rate
puls
oxygen
satur
respiratori
rate
blood
pressur
initi
investig
includ
complet
blood
count
coagul
profil
serum
biochem
test
includ
liver
renal
function
creatin
kinas
lactat
dehydrogenas
electrolyt
patient
monitor
chest
xray
ct
respiratori
specimen
includ
pharyng
swab
bronchoalveolar
lavag
fluid
sputum
bronchial
aspir
test
respiratori
virus
includ
influenza
viru
influenza
b
viru
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
atyp
pathogen
mycoplasma
chlamydia
legionella
pneumophila
also
examin
realtim
rtpcr
routin
bacteri
fungal
examin
also
perform
convent
microbi
cultur
techniqu
treatment
strategi
includ
effect
oxygen
therapi
accord
sever
hypoxemia
nasal
cathetermask
oxygen
inhal
highflow
nasal
cannula
hfnc
noninvas
ventil
niv
support
treatment
ensur
suffici
energi
intak
balanc
electrolyt
acidbas
level
antivir
treatment
includ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
oseltamivir
arbidol
hydrochlorid
atom
inhal
lopinavirritonavir
extracorpor
membran
oxygen
ecmo
support
use
patient
refractori
hypoxemia
difficult
correct
prone
protect
lung
ventil
strategi
nucleic
acid
test
repeat
twice
shown
viru
clearanc
patient
discharg
discontinu
quarantin
review
clinic
chart
nurs
record
laboratori
find
chest
radiographi
patient
laboratoryconfirm
infect
data
epidemiolog
clinic
laboratori
radiolog
featur
treatment
outcom
obtain
standard
data
collect
form
electron
medic
record
critic
ill
patient
admit
icu
glasgow
coma
scale
gc
sequenti
sepsisrel
organ
failur
assess
sofa
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
monitor
day
icu
admiss
two
research
independ
review
data
doubl
check
correct
collect
data
data
avail
electron
medic
record
research
directli
commun
patient
doctor
ascertain
data
integr
clinic
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
outcom
ie
discharg
mortal
hospit
follow
februari
diagnost
criteria
ard
base
berlin
definit
shock
defin
accord
interim
guidanc
novel
coronaviruschina
hypoxemia
defin
partial
arteri
oxygen
pressur
inspiratori
oxygen
fraction
less
mmhg
acut
kidney
injuri
aki
identifi
classifi
highest
serum
creatinin
level
urin
output
criteria
accord
kidney
diseas
improv
global
outcom
classif
cardiac
injuri
diagnos
serum
level
cardiac
biomark
ie
hypersensit
troponin
th
percentil
upper
refer
limit
newli
onset
abnorm
shown
electrocardiogram
cardiac
ultrasound
sever
critic
patient
defin
accord
follow
criteria
fever
plu
one
condit
includ
respiratori
rate
breathsmin
sever
respiratori
distress
room
air
occurr
respiratori
failur
requir
mechan
ventil
shock
organ
failur
continu
variabl
determin
normal
distribut
kolmogorovsmirnov
test
normal
distribut
variabl
describ
mean
standard
deviat
sd
skew
distribut
variabl
express
median
interquartil
rang
iqr
compar
normal
distribut
continu
variabl
use
student
ttest
skew
distribut
variabl
use
mannwhitney
u
test
comparison
categor
variabl
group
conduct
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
funder
studi
role
studi
design
data
collect
data
analysi
interpret
write
manuscript
correspond
author
full
access
data
studi
final
respons
decis
submit
public
studi
popul
includ
total
admit
patient
confirm
infect
zhongnan
hospit
wuhan
univers
januari
respect
patient
sever
patient
patient
nonsever
tabl
whole
studi
popul
patient
histori
exposur
huanan
seafood
market
patient
suffer
secondari
infect
hospit
tabl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
also
significantli
increas
sever
patient
compar
nonsever
patient
tabl
admiss
blood
count
patient
show
leukopenia
white
blood
cell
count
l
show
lymphopenia
lymphocyt
count
l
numer
laboratori
paramet
significantli
increas
sever
patient
tabl
includ
white
blood
cell
neutrophil
prothrombin
time
level
ddimer
hypersensit
troponin
creatin
kinas
creatin
kinasemb
lactat
dehydrogenas
alanin
aspart
aminotransferas
altast
total
bilirubin
serum
creatinin
well
procalcitonin
tabl
p
addit
lymphocyt
count
significantli
decreas
sever
patient
compar
nonsever
patient
tabl
tabl
sever
patient
admit
icu
due
combin
moder
sever
ard
requir
noninvas
invas
mechan
ventil
therapi
median
time
onset
symptom
icu
admiss
day
iqr
tabl
day
icu
admiss
median
gc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
apach
ii
sofa
score
iqr
iqr
iqr
respect
tabl
indic
critic
ill
median
level
patient
icu
mmhg
iqr
median
pf
ratio
mmhg
iqr
common
complic
among
total
subject
includ
ard
arrhythmia
acut
cardiac
injuri
acut
kidney
injuri
aki
shock
compar
nonsever
patient
percentag
sever
patient
complic
significantli
increas
includ
p
significantli
higher
nonsever
patient
tabl
among
sever
patient
patient
receiv
noninvas
ventil
niv
patient
receiv
imv
significantli
higher
nonsever
patient
respect
vs
vs
p
tabl
addit
sever
patient
develop
ard
treat
imv
plu
ecmo
support
aki
patient
underw
crrt
sever
patient
receiv
imvecmo
support
patient
clinic
benefit
discharg
nonsurvivor
rest
patient
still
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
treatment
time
data
collect
figur
repres
chest
ct
significantli
improv
receiv
imvecmo
support
also
analyz
outcom
sever
patient
icu
tabl
patient
symptomat
relief
transfer
gener
ward
dead
rest
patient
still
treatment
patient
higher
score
apach
ii
sofa
increas
level
pct
show
wors
prognosi
tabl
elder
male
patient
increas
mortal
rate
dose
durat
intraven
glucocorticoid
treatment
show
differ
outcom
symptomat
relief
death
tabl
tabl
retrospect
singlecent
studi
includ
total
pneumonia
case
jan
feb
patient
histori
exposur
huanan
seafood
market
major
patient
without
exposur
histori
indic
rapid
humantohuman
transmiss
base
recent
review
estim
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
mean
indic
viru
transmiss
around
higher
estim
also
higher
sarscov
outbreak
approxim
clinic
characterist
analysi
show
significantli
increas
age
well
elev
number
underli
comorbid
sever
patient
nonsever
patient
indic
age
comorbid
may
import
risk
factor
poor
outcom
contradictori
previou
report
show
higher
incid
male
patient
recent
data
includ
consist
show
similar
proport
male
femal
patient
patient
also
demonstr
decreas
lymphat
count
compar
healthi
peopl
significantli
decreas
sever
patient
compar
nonsever
patient
data
show
lymphocytopenia
occur
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
may
mediat
cell
proapoptosi
addit
abnorm
laboratori
find
sever
patient
also
includ
prolong
thrombin
time
increas
astast
hypersensit
troponin
serum
creatin
suggest
aberr
coagul
pathway
hepat
injuri
myocardi
injuri
kidney
injuri
respect
level
pct
marker
suggest
bacteri
infect
elev
patient
suggest
viralmedi
pneumonia
rather
bacteria
laboratori
abnorm
similar
previous
observ
patient
merscov
rate
coinfect
includ
virus
bacteria
fungu
significantli
increas
sever
patient
nonsever
patient
coinfect
rate
also
higher
death
group
icutoward
transfer
group
despit
significantli
statist
differ
due
small
number
case
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
improv
symptom
underli
diseas
activ
prevent
potenti
complic
secondari
infect
like
virus
enter
cell
receptormedi
endocytosi
studi
show
may
infect
alveolar
epitheli
cell
lung
angiotensinconvert
enzym
ii
receptor
also
express
tissu
kidney
blood
vessel
heart
research
use
artifici
intellig
predict
baricitinib
inhibitor
protein
kinas
might
use
interrupt
entranc
viru
cell
also
intracellular
assembl
viru
particl
addit
case
report
show
remdesivir
adenosin
analogu
shown
surviv
benefit
one
sever
pneumonia
patient
effect
verifi
vitro
coupl
clinic
trial
focu
efficaci
remdesivir
well
therapeut
strategi
immunoglobulin
vitamin
c
infus
mesenchym
stem
cell
treatment
arbidol
hydrochlorid
plu
interferon
atom
ritonavir
combin
oseltamivir
lopinavir
plu
ritonavir
arbidol
hydroxychloroquin
methylprednisolon
corticosteroid
therapi
regard
onset
therapeut
time
dosag
durat
still
controversi
treatment
sever
sar
pneumonia
treat
corticosteroid
patient
refractori
high
fever
exacerb
wheez
symptom
increas
interstiti
exud
base
chest
radiolog
high
level
inflammatori
mediat
inhibit
cytokin
storm
corticosteroid
therapi
methylprednisolon
mgkgday
recommend
sever
ill
patient
ard
short
durat
treatment
possibl
result
show
earli
onset
use
corticosteroid
may
clinic
benefit
case
multivari
correl
analysi
regard
safeti
efficaci
need
verifi
data
also
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
suggest
excess
fluid
resuscit
may
increas
risk
death
one
principl
ard
treatment
restrict
fluid
resuscit
strategi
prevent
exacerb
pulmonari
edema
limit
studi
among
case
patient
still
hospit
time
data
collect
incomplet
assess
risk
factor
outcom
continu
observ
dynam
clinic
dataset
requir
singlecent
case
seri
hospit
patient
confirm
wuhan
china
sever
patient
elder
age
chronic
comorbid
develop
one
complic
receiv
icu
care
transfer
gener
ward
due
reliev
symptom
mortal
rate
sever
patient
icu
nonsever
patient
cure
discharg
patient
die
older
male
patient
higher
apach
ii
sofa
score
elev
pct
level
excess
fluid
volum
input
well
delay
use
corticosteroid
might
increas
risk
death
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
evalu
ii
score
sofa
sequenti
organ
failur
assess
score
pct
procalcitonin
cumul
fluid
balanc
total
fluid
input
minu
output
icu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
